What volume in milliliters of standard dextromethorphan syrup should be administered per dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dextromethorphan Dosing in Milliliters

For adults and children 12 years and older, administer 10 mL every 12 hours; for children 6 to under 12 years, give 5 mL every 12 hours; for children 4 to under 6 years, give 2.5 mL every 12 hours. 1

Age-Based Dosing Algorithm

The FDA-approved dosing for standard dextromethorphan extended-release oral suspension (containing 30 mg dextromethorphan hydrobromide per 5 mL) is straightforward 1:

Specific Volumes by Age:

  • Adults and children ≥12 years: 10 mL every 12 hours

    • Maximum: 20 mL in 24 hours
  • Children 6 to <12 years: 5 mL every 12 hours

    • Maximum: 10 mL in 24 hours
  • Children 4 to <6 years: 2.5 mL every 12 hours

    • Maximum: 5 mL in 24 hours
  • Children <4 years: Do not use 1

Critical Administration Points

Always shake the bottle well before use and measure only with the dosing cup provided with the product. Do not use the dosing cup with other products, as concentration varies between formulations 1.

Evidence Context

While the 2006 ACCP guidelines show mixed evidence for dextromethorphan's efficacy in cough suppression—with some studies showing benefit at 30-60 mg doses and others showing no significant effect 2—the FDA-approved dosing remains the standard for clinical practice. The guideline evidence demonstrates that dextromethorphan at 60 mg reduced cough counts by 50% in chronic bronchitis patients, while 30 mg showed variable results 2.

Important Caveats

  • The extended-release formulation (polistirex) provides 12-hour coverage, which differs from immediate-release formulations that may require more frequent dosing
  • This dosing applies specifically to the extended-release oral suspension formulation 1
  • Patients with CYP2D6 polymorphisms (approximately 6% of Black Americans and 5-10% of white populations) may have altered metabolism, though standard dosing typically remains appropriate 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.